M. Hamed Farooqi
Currently interested in the application of technology towards remote patient monitoring as well as integration of artificial intelligence in the clinical decision making process.
Dr. Farooqi received his Internal Medicine training in New York and then did his Endocrine Fellowship at Thomas Jefferson University Hospital in Philadelphia.
He is US Board Certified in Internal Medicine and Endocrinology and is a Fellow of the American College of Endocrinology, the American College of Physicians, the Royal College of Physicians (Glasgow) and the Royal Society of Public Health, UK.
At present, he is a Professor at the Dubai Medical College and is also on the faculty of Mohammad Bin Rashid University of Health Sciences in Dubai.
Initially he joined the Joslin Diabetes Center Affiliate in Florida and worked there for a decade as the Medical Director. He established and operated a highly successful Joslin affiliate in Safety Harbor, Florida. In 2008, he lead the Joslin team that set up the state of the art Joslin Diabetes Center Affiliate at Dubai Health Authority, now renamed as the Dubai Diabetes Center, one of the largest in the public sector in the UAE. It is an IDF Center of Excellence and an accredited JCI facility.
His passions include teaching. He has won multiple awards for teaching students while serving as an Associate Professor at the University of South Florida.
Dr. Farooqi has been an invited speaker at various Health Forums internationally and has helped design global diabetes education programs for primary care physicians as a faulty member of the Department of Global Health and Social Medicine, Harvard Medical School.
He has published many articles and serves as a reviewer or member of the editorial board of various international journals.
Authors: Kalra S, Farooqi MH, El-Houni AE.
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):686-90. doi: 10.4103/2230-8210.163214.
Glycemic and lipids control in patients with diabetes and cardiovascular or renal diseases across all the government health sectors in the Emirate of Dubai,
United Arab Emirates.
Authors: Rashid F, Abdelgadir E, Alsaeed M, Alemadi B, Khalifa A, Farooqi MH, Alawadi, F, Bashier A.
Diabetes Metab Syndr. 2019 Jan-Feb;13(1):590-594. doi:
10.1016/j.dsx.2018.11.013. Epub 2018 Nov 9.
Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year Pattern.
Authors: Abdelgadir E, Alsaeed M, Hafidh K, Bashier A, Rashid F, Altayb F, Sayyah F, Farooqi MH, Alawadi F.
Oman Med J. 2019 Jul;34(4):290-296. doi: 10.5001/omj.2019.58.
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern.
Authors: Alawadi F, Abdelgadir E, Bashier A, Hassanein M, Rashid F, Alsaeed M, Hafidh
K, Elsayed MA, Abuelkheir S, Farooqi MH.
Oman Med J. 2019 Jan;34(1):20-25. doi: 10.5001/omj.2019.04.
Management of nonalcoholic fatty liver disease in the Middle East.
Authors: Sanai FM, Abaalkhail F, Hasan F, Farooqi MH, Nahdi NA, Younossi ZM.
World J Gastroenterol. 2020 Jul 7;26(25):3528-3541. doi:10.3748/wjg.v26.i25.3528.
Prevalence of Diabetes among Migrant Women and Duration of Residence in the United Arab Emirates: A Cross Sectional Study.
Authors: Shah SM, Ali R, Loney T, Aziz F, ElBarazi I, Al Dhaheri S, Farooqi MH, Blair I.
PLoS One. 2017 Jan 18;12(1):e0169949. doi: 10.1371/journal.pone.0169949. eCollection 2017.
Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment.
Authors: Leonard DR, Farooqi MH, Myers S.
Diabetes Care. 2004 Jan;27(1):168-72. doi: 10.2337/diacare.27.1.168.
PMID: 14693984 Clinical Trial.
View full abstract on Pubmed